161 related articles for article (PubMed ID: 23873238)
1. Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy.
Chu S; Karimi S; Peck KK; Yamada Y; Lis E; Lyo J; Bilsky M; Holodny AI
Spine (Phila Pa 1976); 2013 Oct; 38(22):E1418-24. PubMed ID: 23873238
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy.
Lis E; Saha A; Peck KK; Zatcky J; Zelefsky MJ; Yamada Y; Holodny AI; Bilsky MH; Karimi S
Neurosurg Focus; 2017 Jan; 42(1):E9. PubMed ID: 28041318
[TBL] [Abstract][Full Text] [Related]
3. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.
Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR
Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017
[TBL] [Abstract][Full Text] [Related]
4. Use of dynamic contrast-enhanced MRI for the early assessment of outcome of CyberKnife stereotactic radiosurgery for patients with spinal metastases.
Chen Y; Zhang E; Wang Q; Yuan H; Zhuang H; Lang N
Clin Radiol; 2021 Nov; 76(11):864.e1-864.e6. PubMed ID: 34404514
[TBL] [Abstract][Full Text] [Related]
5. T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine.
Guan Y; Peck KK; Lyo J; Tisnado J; Lis E; Arevalo-Perez J; Yamada Y; Hameed MR; Karimi S; Holodny A
Radiology; 2020 Nov; 297(2):382-389. PubMed ID: 32870135
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging parameter changes as an early biomarker of tumor responses following radiation therapy in patients with spinal metastases: a systematic review.
Mulyadi R; Putri PP; Handoko H; Zairinal RA; Prihartono J
Radiat Oncol J; 2023 Dec; 41(4):225-236. PubMed ID: 38185927
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.
Saha A; Peck KK; Lis E; Holodny AI; Yamada Y; Karimi S
Spine (Phila Pa 1976); 2014 Nov; 39(24):E1433-40. PubMed ID: 25188594
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
10. Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography.
Huang YS; Chen JL; Chen JY; Lee YF; Huang JY; Kuo SH; Yen RF; Chang YC
Strahlenther Onkol; 2019 Aug; 195(8):707-718. PubMed ID: 30610356
[TBL] [Abstract][Full Text] [Related]
11. A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion MRI to Predict Local Recurrence After Radiosurgery on Spinal Metastases.
Kumar KA; Peck KK; Karimi S; Lis E; Holodny AI; Bilsky MH; Yamada Y
Technol Cancer Res Treat; 2017 Dec; 16(6):857-865. PubMed ID: 28449626
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
Thomas AA; Arevalo-Perez J; Kaley T; Lyo J; Peck KK; Shi W; Zhang Z; Young RJ
J Neurooncol; 2015 Oct; 125(1):183-90. PubMed ID: 26275367
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
Lang N; Yuan H; Yu HJ; Su MY
Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
15. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.
Haeck J; Bol K; Bison S; van Tiel S; Koelewijn S; de Jong M; Veenland J; Bernsen M
Contrast Media Mol Imaging; 2015; 10(6):413-20. PubMed ID: 25995102
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective study.
Vellayappan B; Cheong D; Singbal S; Tey J; Yang Soon Y; Nang Leong C; Wong A; Lwin S; Hung Lee C; Periasamy P; Lo S; Kumar N
Radiol Oncol; 2022 Dec; 56(4):525-534. PubMed ID: 36503714
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of spinal metastases originated from lung and other cancers using radiomics and deep learning based on DCE-MRI.
Lang N; Zhang Y; Zhang E; Zhang J; Chow D; Chang P; Yu HJ; Yuan H; Su MY
Magn Reson Imaging; 2019 Dec; 64():4-12. PubMed ID: 30826448
[TBL] [Abstract][Full Text] [Related]
18. Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization.
Cristel G; Esposito A; Damascelli A; Briganti A; Ambrosi A; Brembilla G; Brunetti L; Antunes S; Freschi M; Montorsi F; Del Maschio A; De Cobelli F
Eur J Radiol; 2019 Sep; 118():51-57. PubMed ID: 31439258
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance perfusion compared with digital subtraction angiography for the evaluation of extradural spinal metastases: a pilot study.
Mazura JC; Karimi S; Pauliah M; Banihashemi MA; Gobin YP; Bilsky MH; Patsalides A
Spine (Phila Pa 1976); 2014 Jul; 39(16):E950-4. PubMed ID: 24827525
[TBL] [Abstract][Full Text] [Related]
20. Dependence of DCE-MRI biomarker values on analysis algorithm.
Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
